Current Clinical Trials

Below you find an excerpt of studies that are currently conducted at the VTC:

A controlled, two-arm epidemiologic study on advanced dry age related macular degeneration.

A randomized, double-masked, eight-arm phase III evaluation of intravitreal treatment for advanced dry age related macular degeneration.

A randomized, double-masked, two-arm phase III non-inferiority study comparing a humanized single-chain antibody fragment to Ranibizumab in patients with neovascular age related macular degeneration.

A randomized, open label, two-arm phase IIIb comparison of different treatment regiments for neovascular macular degeneration with a recombinant fusion protein.

A randomized, open label phase VI study to evaluate treatment results for diabetic macular edema with a recombinant fusion protein.

A randomized, open label phase IIIb comparison of different treatment regiments with a recombinant fusion protein for diabetic macular edema.

A controlled, open-label intervention study for Hereditary Optic Neuropathy treatment with an antioxidant.

A controlled, open-label non-intervention study for Hereditary Optic Neuropathy treatment with an antioxidant.

A randomized, open-label, two-arm phase III treatment comparison in retinopathy of prematurity.

Ophthalmological safety evaluation for a double-blinded phase III study with a MEK inhibitor for advanced melanoma.

Ophthalmological safety evaluation for a double-blinded phase III comparison of JAK inhibitors for myelofibrosis.

Ophthalmological evaluation for a phase III study of a S1-P1-modulator for multiple sclerosi.